XML 26 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
Document Period End Date Jun. 30, 2018    
Cash flows from operating activities      
Net income (loss) $ 1,712 $ (1,792) $ (56,024)
Adjustments to reconcile net income (loss) to net cash used in operations      
Depreciation of property and equipment 3,730 3,917 3,686
Provision for (recovery of) doubtful accounts (including note receivable) (225) 465 725
Amortization of patents 204 218 231
Write-off of patent costs 497 733 168
Loss on disposal of property and equipment 16 158 170
Stock-based compensation 10,302 10,354 12,977
Other 0 138 0
Changes in assets and liabilities      
Accounts receivable (2,878) (5,809) 7,327
Inventories 292 543 (3,474)
Prepaid expenses and other assets 2,308 (1,823) 728
Accounts payable 104 1,761 (970)
Accrued expenses and other liabilities (6,577) 725 10,873
Deferred revenue 189 10,000 0
Net cash provided by (used in) operating activities 9,674 19,588 (23,583)
Cash flows from investing activities      
Expenditures for property and equipment (1,956) (981) (3,818)
Purchase of investment (2,538) 0 0
Proceeds from (issuance of) convertible note receivable 318    
Proceeds from (issuance of) convertible note receivable   0 (350)
Purchases of marketable securities 0 0 (37)
Sales of marketable securities 194 46 1,249
Costs incurred in connection with patents (1,113) (844) (813)
Net cash used in investing activities (5,095) (1,779) (3,769)
Cash flows from financing activities      
Proceeds from the employee stock purchase plan 3,242 3,254 3,142
Exercise of stock options 513 5,263 1,006
Proceeds from financing 20,944 0
Other 14 4 0
Net cash provided by financing activities 3,769 29,465 4,148
Net change in cash and cash equivalents 8,348 47,274 (23,204)
Cash and cash equivalents      
Beginning of period 107,912 60,638 83,842
End of period 116,260 107,912 60,638
Noncash investing and financing activities      
Change in equipment included in accounts payable 162 (319) (374)
Change in patent costs included in accounts payable 237 (150) 87
Supplemental cash flow information      
Interest paid $ 1,717 $ 500 $ 0